Related Experiment Video
Updated: Mar 13, 2026
04:53
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
1.6K
[Obesity and obstructive sleep apnea in children]
A Amaddeo1, L de Sanctis2, J Olmo Arroyo2
1Unité de ventilation noninvasive et du sommeil de l'enfant, hôpital universitaire Necker-Enfants-Malades, AP-HP, 149, rue de Sèvres, 75015 Paris, France; Université Paris Descartes, Paris, France; Équipe 13, Inserm U955, 94000 Créteil, France.
Summary
Obesity is a significant risk factor for childhood obstructive sleep apnea (OSA), increasing its severity and persistence. Preventing childhood obesity is key to reducing OSA incidence and associated health problems.
Area of Science:
- Pediatric Sleep Medicine
- Childhood Obesity Research
Background:
- Obesity is a primary risk factor for obstructive sleep apnea (OSA) in children.
- It exacerbates OSA prevalence, severity, and long-term persistence.
- Neurocognitive and behavioral issues are frequent morbidities in pediatric OSA.
Purpose of the Study:
- To examine the role of obesity in pediatric obstructive sleep apnea (OSA).
- To understand the impact of obesity on OSA-associated morbidities and treatment outcomes in children.
Main Methods:
- Review of existing literature on obesity, OSA, and pediatric health outcomes.
- Analysis of the complex interactions between sleep, OSA, obesity, and metabolic factors.
Main Results:
- Obesity increases OSA prevalence and severity in children.
- Treatment efficacy, particularly adenotonsillectomy, is reduced in obese children.
- Obese children face higher perioperative complication risks and suboptimal CPAP compliance.
Conclusions:
- Obesity is a critical public health issue impacting pediatric OSA.
- Preventing childhood obesity is essential for reducing OSA incidence and morbidity.
- Further research is needed to clarify obesity's precise role in OSA-associated end-organ damage.
Related Concept Videos
01:21Sleep Apnea
693
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
693
01:24Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
342
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
342
01:17Other Pulmonary Disorders
1.8K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.8K
01:21Drug Dosing: Obese Patients
325
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
325
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
262
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
262